Home > Insider Trading > Filing (0001213900-21-003298)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1733413	Tff Pharmaceuticals Inc.	TFFP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1568678	R. Glenn Mattes	2600 Via Fortuna, Suite 360 Austin TX 78746	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-09-25	3,000	$17.00	7,000	No	4	S	Indirect	By Spouse
Common Stock	Acquisiton	2021-01-15	40,000	$2.50	50,000	No	4	M	Direct
Common Stock	Disposition	2021-01-15	40,000	$17.51	10,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Spouse
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2021-01-15	40,000	$0.00	40,000	$2.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,034,227	2019-05-01	2028-05-01	No	4	M	Direct

Footnotes

The transactions reported by this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2020.
The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options.
200,000 shares of the option vested and became exercisable on May 1, 2019.